AKT1 dysregulation leads to tumorigenesis processes, including cancer cell proliferation, growth and survival [35], tumor angiogenesis [36], recruitment of inflammatory cells required for the tumor microenvironment [37] and resistance to apoptosis [38]. The gene discussed is AKT1; the disease is cancer.